Table 2.

Association between HALP score and all-cause mortality at 90 days and 365 days.

Variables		Model 1		Model 2		Model 3
		HR (95% CI)	p-value	HR (95% CI)	p-value	HR (95% CI)	p-value
90 days mortality
HALP quartile
	Q1	1.00 (Reference)		1.00 (Reference)		1.00 (Reference)
	Q2	0.95 (0.68$\sim$1.13)	0.737	0.91 (0.66$\sim$1.26)	0.567	0.84 (0.60$\sim$1.17)	0.298
	Q3	0.69 (0.48$\sim$0.97)	0.035	0.67 (0.49$\sim$0.98)	0.040	0.66 (0.46$\sim$0.96)	0.029
	Q4	0.66 (0.46$\sim$0.94)	0.020	0.65 (0.46$\sim$0.92)	0.016	0.68 (0.47$\sim$0.99)	0.047
p for trend			0.005		0.006		0.022
365 days mortality
HALP quartile
	Q1	1.00 (Reference)		1.00 (Reference)		1.00 (Reference)
	Q2	0.87 (0.65$\sim$1.16)	0.341	0.83 (0.63$\sim$1.11)	0.218	0.80 (0.60$\sim$1.08)	0.152
	Q3	0.71 (0.52$\sim$0.95)	0.023	0.70 (0.52$\sim$0.95)	0.022	0.69 (0.50$\sim$0.94)	0.020
	Q4	0.63 (0.47$\sim$0.86)	0.004	0.62 (0.46$\sim$0.85)	0.003	0.66 (0.47$\sim$0.90)	0.011
p for trend			0.001		0.001		0.006

Model 1: Crude.

Model 2: Adjusted for Age and Gender.

Model 3: Adjusted for Age, Gender, Race, RR, SBP, DBP, SPO₂, WBC, PCO₂, Potassium, Sodium, GLU, Anion gap, lactate, PTT, AF, CA, CKD, CHF, COPD, Diabetes, Hypertension, Stroke, Clopidogrel, Beta-blockers, Statin, Invasive MV, and Noninvasive MV.

HR, Hazard Ratio; CI, Confidence Interval.